BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37705380)

  • 1. Incidence of cutaneous T-cell lymphoma in the Republic of Ireland between 1994 and 2019.
    McFeely O; Walsh PM; Desmond R; Enright H; Costa Blasco M; Wolinska A; Murphy L; Andrawis M; Beatty P; Doyle C; Tobin AM; O'Gorman S; Molloy K
    J Eur Acad Dermatol Venereol; 2024 Feb; 38(2):e145-e147. PubMed ID: 37705380
    [No Abstract]   [Full Text] [Related]  

  • 2. Demographic Patterns and Increasing Incidence of Cutaneous T-Cell Lymphoma in Louisiana.
    Maghfour J; Gill F; Olson J; Guido N; Echuri H; Murina A
    JAMA Oncol; 2022 Aug; 8(8):1218-1220. PubMed ID: 35708682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping cutaneous T-cell lymphoma in the state of Florida: A retrospective exploratory spatial analysis of incidence patterns.
    Malachowski SJ; Moy A; Messina J; Chen YA; Sun J; Sokol L; Seminario-Vidal L
    J Am Acad Dermatol; 2022 Jan; 86(1):186-188. PubMed ID: 33476732
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative clinicopathologic analysis of cutaneous peripheral T-cell lymphoma, not otherwise specified, according to primary tumor site.
    Lee MH; Choi ME; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
    J Am Acad Dermatol; 2019 Jun; 80(6):1771-1774. PubMed ID: 30296539
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of airborne toxins with geographic clustering of cutaneous T-cell lymphoma in Louisiana.
    Maghfour J; Gill F; Olson J; Guido N; Echuri H; Murina A
    J Am Acad Dermatol; 2022 Nov; 87(5):1184-1186. PubMed ID: 35271939
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidemiology of primary cutaneous γδ T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the U.S.A. from 2006 to 2015: a Surveillance, Epidemiology, and End Results-18 analysis.
    Goyal A; Goyal K; Bohjanen K; Pearson D
    Br J Dermatol; 2019 Oct; 181(4):848-850. PubMed ID: 30951189
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous T-cell lymphoma in Colorado 1974-1991.
    Bunker JD; Freeman JH; Jester JD; Golitz LE
    J Dermatol; 1991 Jul; 18(7):369-76. PubMed ID: 1791245
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study.
    Maurelli M; Tessari G; Colato C; Schena D; Girolomoni G
    Eur J Dermatol; 2018 Feb; 28(1):44-49. PubMed ID: 29171395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study.
    Geskin LJ; Kwinta BD; Garcia-Saleem TJ; Akilov OE; Enz PA; Guenova E; Ortiz-Romero PL; Papadavid E; Quaglino P; Rozati S; Stonesifer CJ; Burns A; Stringer WS; Tarin E; Scarisbrick JJ
    J Am Acad Dermatol; 2023 Apr; 88(4):935-937. PubMed ID: 36375717
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical characteristics of primary cutaneous lymphoma: analysis from two centres in China.
    Shi HZ; Liu YX; Jiang YQ; Chen SL; Xu XL; Lu XM; Zhang W; Zeng XS; Zhou GZ; Sun JF; Chen H
    Br J Dermatol; 2019 Dec; 181(6):1332-1333. PubMed ID: 31260087
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous malignancies: KA, CTCL, and KS.
    Vargo N
    Dermatol Nurs; 2006 Jun; 18(3):270, 277. PubMed ID: 16856684
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018: A SEER Population Data Analysis.
    Cai ZR; Chen ML; Weinstock MA; Kim YH; Novoa RA; Linos E
    JAMA Oncol; 2022 Nov; 8(11):1690-1692. PubMed ID: 36048455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database.
    Dequidt L; Franck N; Sanchez-Pena P; Dalle S; Adamski H; Boulinguez S; Ingen-Housz-Oro S; Ram-Wolff C; Boccara O; Bonnet N; Cortes B; Gouraud A; Grange F; Le Corre Y; Quereux G; De Masson A; Schmutz JL; Skowron F; Verneuil L; Beylot-Barry M
    Br J Dermatol; 2019 Sep; 181(3):616-618. PubMed ID: 30835817
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous T-cell lymphoma. Preface.
    Bagot M
    Dermatol Clin; 2008 Jan; 26 Suppl 1():V. PubMed ID: 18405179
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics of primary cutaneous lymphomas in Tehran, Iran (1998-2004).
    Manuchehri HM; Rakhshan M
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):758-60. PubMed ID: 16836523
    [No Abstract]   [Full Text] [Related]  

  • 16. Changing incidence trends of cutaneous B-cell lymphoma.
    Korgavkar K; Weinstock MA
    J Invest Dermatol; 2014 Mar; 134(3):840-842. PubMed ID: 24037340
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances on cutaneous lymphoma epidemiology.
    Dobos G; Miladi M; Michel L; Ram-Wolff C; Battistella M; Bagot M; de Masson A
    Presse Med; 2022 Mar; 51(1):104108. PubMed ID: 35026392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T-cell lymphoma epidemiology: patients providing the power.
    Lessin SR
    Arch Dermatol; 2007 Jul; 143(7):916-8. PubMed ID: 17638738
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence of primary cutaneous T-cell lymphoma in Wales.
    Abbott RA; Aldridge C; Dojcinov S; Piguet V
    Br J Dermatol; 2013 Dec; 169(6):1366-7. PubMed ID: 23855741
    [No Abstract]   [Full Text] [Related]  

  • 20. The spectrum of cutaneous lymphomas in patients less than 20 years of age.
    Fink-Puches R; Chott A; Ardigó M; Simonitsch I; Ferrara G; Kerl H; Cerroni L
    Pediatr Dermatol; 2004; 21(5):525-33. PubMed ID: 15461755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.